睡眠障碍市场机会、成长驱动因素、产业趋势分析与预测 2025 - 2034

全球睡眠障碍市场预计2024 年价值276 亿美元，预计2025 年至2034 年将以10.1% 的复合年增长率强劲增长。的需求不断增长推动的。

受失眠、睡眠呼吸中止症和发作性睡病等睡眠障碍影响的人数不断增加，是推动市场的关键因素之一。现代生活方式的特点是压力更大、睡眠模式不规则和过度使用数位设备，这些都导致​​了睡眠相关问题的激增。随着越来越多的人遇到睡眠困难，对药物、治疗设备和先进诊断工具等各种治疗的需求不断增加。

此外，人们对睡眠对整体健康重要性的认识不断加深，也增强了大众的意识。睡眠不佳与各种慢性健康问题有关，包括心血管疾病、肥胖和心理健康问题，促使更多人寻求解决方案。健康运动和教育措施正在传播有关解决睡眠障碍重要性的讯息，从而刺激了对诊断服务和治疗方案（包括疗法和设备）的需求。

此市场按疾病类型分类，包括睡眠呼吸中止症、不宁腿症候群 (RLS)、失眠、发作性睡病等。睡眠呼吸中止症是最大的贡献者，占据了市场的很大一部分。这种疾病，特别是其阻塞性形式，非常普遍，尤其是在老年族群和具有其他危险因子的个体中。随着人们对睡眠呼吸中止症的认识不断提高，对诊断和治疗解决方案的需求激增，进一步巩固了该领域的市场主导地位。

治疗领域预计将推动显着成长，预计复合年增长率为10.5%，到2034 年将达到472 亿美元以上。了关键作用。 CPAP 机等提供恆定气流以保持呼吸道畅通的设备已得到改进，以提高舒适度和易用性。睡眠障碍治疗保险的广泛采用也使得治疗变得更加容易，鼓励更多的人寻求治疗。

就最终用途而言，市场分为家庭护理场所和睡眠实验室。在日益增长的自我管理趋势的支持下，家庭照护环境占据了市场主导地位。创新的家用诊断和治疗设备，例如穿戴式睡眠追踪器和便携式 CPAP 机，使个人能够更轻鬆地在舒适的家中监测和治疗睡眠障碍。

北美在睡眠障碍市场中占有很大份额，到 2024 年价值将达到 106 亿美元。公众意识、保险覆盖范围和人口老化进一步巩固了北美在全球市场的地位。

目录

第 1 章：方法与范围

第 2 章：执行摘要

第 3 章：产业洞察

• 产业生态系统分析
• 产业影响力
  • 成长动力
    • 睡眠障碍的盛行率不断上升
    • 对便携式、高效、优质的睡眠障碍设备的需求不断增长
    • 提高对睡眠障碍的认识
    • 睡眠科技设备的技术进步
  • 产业陷阱与挑战
    • 严格的监管框架
• 成长潜力分析
• 技术景观
• 未来市场趋势
• 监管环境
• 报销场景
• 差距分析
• 波特的分析
• PESTEL分析

第 4 章：竞争格局

• 介绍
• 公司矩阵分析
• 主要市场参与者的竞争分析
• 竞争定位矩阵
• 战略仪表板

第 5 章：市场估计与预测：按疾病类型，2021 - 2034 年

• 主要趋势
• 睡眠呼吸中止症
  • 阻塞性睡眠呼吸中止症
  • 中枢性睡眠呼吸中止/复杂性睡眠呼吸暂停
  • 复杂的睡眠呼吸中止症
• 不宁腿症候群（RLS）
• 失眠
• 发作性睡病
• 其他疾病

第 6 章：市场估计与预测：按产品分类，2021 - 2034 年

• 主要趋势
• 诊断
  • 多导睡眠图 (PSG) 装置
    • 流动 PSG 设备
    • 临床 PSG 设备
  • 居家睡眠测试 (HST) 设备
    • 2型
    • 3型
    • 4型
  • 体动记录系统
  • 睡眠筛检设备
  • 脉搏血氧仪
  • 呼吸测谎仪
  • 穿戴式装置
    • 智慧手錶和手环
    • 其他穿戴式装置
• 疗法
  • 认知行为疗法
  • 治疗设备
    • 气道正压通气 (PAP) 装置
      • 持续性呼吸道正压通气 (CPAP) 设备
      • 双水平气道正压通气 (BiPAP) 装置
      • 自动气道正压通气 (APAP) 装置
    • 口腔矫正器
      • 下颚前移装置
      • 舌头固定装置
      • 上颚快速扩张
      • 护齿套
    • 自适应伺服通气 (ASV)
    • 气道清理系统
    • 制氧装置
    • 其他治疗装置

第 7 章：市场估计与预测：按最终用途，2021 - 2034 年

• 主要趋势
• 居家照护机构及个人
• 睡眠实验室和医院

第 8 章：市场估计与预测：按地区划分，2021 - 2034 年

• 主要趋势
• 北美洲
  • 我们
  • 加拿大
• 欧洲
  • 德国
  • 英国
  • 法国
  • 西班牙
  • 义大利
  • 荷兰
• 亚太地区
  • 中国
  • 日本
  • 印度
  • 澳洲
  • 韩国
• 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
• 中东和非洲
  • 南非
  • 沙乌地阿拉伯
  • 阿联酋

第 9 章：公司简介

• Apple
• Asahi Kasei Corporation
• BMC Medical
• Cadwell Laboratories
• Drive DeVilbiss International
• Fisher & Paykel Healthcare
• Fitbit
• Koninklijke Philips NV
• LivaNova
• Natus Medical
• Nihon Kohden
• Oura Health
• ResMed
• Sleep Shepherd
• Sleepace
• Teleflex
• WEINMANN Emergency Medical Technology GmbH + Co. KG
• Withings
• Xiaomi

The Global Sleep Disorder Market, valued at USD 27.6 billion in 2024, is projected to grow at a robust CAGR of 10.1% from 2025 to 2034. This growth is primarily driven by the increasing prevalence of sleep disorders, the rising demand for advanced and portable treatment devices, and heightened awareness about sleep health.

The rising number of individuals affected by sleep disorders such as insomnia, sleep apnea, and narcolepsy is one of the key factors propelling the market. Modern lifestyles, characterized by higher stress levels, irregular sleep patterns, and excessive use of digital devices, have contributed significantly to the surge in sleep-related issues. As more people experience difficulties with sleep, the demand for a variety of treatments, including medications, therapeutic devices, and advanced diagnostic tools, has escalated.

Moreover, the growing understanding of the importance of sleep for overall health has amplified public awareness. Poor sleep has been linked to various chronic health issues, including cardiovascular disease, obesity, and mental health conditions, prompting more people to seek solutions. Health campaigns and educational initiatives are spreading the message about the importance of addressing sleep disorders, thus fueling demand for diagnostic services and treatment options, including therapies and devices.

The market is categorized by the type of disorder, with segments including sleep apnea, restless leg syndrome (RLS), insomnia, narcolepsy, and others. Sleep apnea is the largest contributor, accounting for a significant portion of the market. The disorder, particularly its obstructive form, is highly prevalent, especially among aging populations and individuals with other risk factors. As awareness surrounding sleep apnea continues to grow, the demand for both diagnostic and therapeutic solutions has surged, further cementing the market dominance of this segment.

The therapeutics segment is expected to drive significant growth, with a projected CAGR of 10.5%, reaching over USD 47.2 billion by 2034. Technological upgrades in therapeutic devices, especially for sleep apnea, have played a key role in this expansion. Devices like CPAP machines, which provide constant airflow to keep airways open, have been improved for better comfort and ease of use. The widespread adoption of insurance coverage for sleep disorder treatments has also made therapies more accessible, encouraging more individuals to seek treatment.

In terms of end use, the market is divided into home care settings and sleep laboratories. Home care settings, supported by the growing trend of self-management, dominate the market. Innovative home-based diagnostic and therapeutic devices, such as wearable sleep trackers and portable CPAP machines, have made it easier for individuals to monitor and treat sleep disorders from the comfort of their homes.

North America holds a significant share of the sleep disorder market, valued at USD 10.6 billion in 2024. The region's large population affected by sleep disorders, coupled with high access to specialized sleep care and advanced sleep technologies, is fueling market growth. Public awareness, insurance coverage, and the aging population further solidify North America's position in the global market.

Table of Contents

Chapter 1 Methodology and Scope

• 1.1 Market scope and definitions
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Base estimates and calculations
  • 1.3.1 Base year calculation
  • 1.3.2 Key trends for market estimation
• 1.4 Forecast model
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
  • 1.5.2 Data mining sources

Chapter 2 Executive Summary

• 2.1 Industry 360° synopsis

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Growing prevalence of sleep disorders
    • 3.2.1.2 Rising demand for portable, efficient, and superior devices for sleep disorders
    • 3.2.1.3 Increasing awareness regarding sleep disorders
    • 3.2.1.4 Technological advancements in sleep tech devices
  • 3.2.2 Industry pitfalls and challenges
    • 3.2.2.1 Stringent regulatory framework
• 3.3 Growth potential analysis
• 3.4 Technology landscape
• 3.5 Future market trends
• 3.6 Regulatory landscape
• 3.7 Reimbursement scenario
• 3.8 Gap analysis
• 3.9 Porter's analysis
• 3.10 PESTEL analysis

Chapter 4 Competitive Landscape, 2024

• 4.1 Introduction
• 4.2 Company matrix analysis
• 4.3 Competitive analysis of major market players
• 4.4 Competitive positioning matrix
• 4.5 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Disorder Type, 2021 - 2034 ($ Mn)

• 5.1 Key trends
• 5.2 Sleep apnea
  • 5.2.1 Obstructive sleep apnea
  • 5.2.2 Central sleep apnea/Complex sleep apnea
  • 5.2.3 Complex sleep apnea
• 5.3 Restless legs syndrome (RLS)
• 5.4 Insomnia
• 5.5 Narcolepsy
• 5.6 Other disorders

Chapter 6 Market Estimates and Forecast, By Product, 2021 - 2034 ($ Mn)

• 6.1 Key trends
• 6.2 Diagnostics
  • 6.2.1 Polysomnography (PSG) device
    • 6.2.1.1 Ambulatory PSG devices
    • 6.2.1.2 Clinical PSG devices
  • 6.2.2 Home sleep testing (HST) devices
    • 6.2.2.1 Type 2
    • 6.2.2.2 Type 3
    • 6.2.2.3 Type 4
  • 6.2.3 Actigraphy systems
  • 6.2.4 Sleep screening devices
  • 6.2.5 Pulse oximeter
  • 6.2.6 Respiratory polygraph
  • 6.2.7 Wearables
    • 6.2.7.1 Smart watches and bands
    • 6.2.7.2 Other wearables
• 6.3 Therapeutics
  • 6.3.1 Cognitive behavioral therapy
  • 6.3.2 Therapeutic devices
    • 6.3.2.1 Positive airway pressure (PAP) devices
      • 6.3.2.1.1 Continuous positive airway pressure (CPAP) devices
      • 6.3.2.1.2 Bilevel positive airway pressure (BiPAP) devices
      • 6.3.2.1.3 Automatic positive airway pressure (APAP) devices
    • 6.3.2.2 Oral appliances
      • 6.3.2.2.1 Mandibular advancement devices
      • 6.3.2.2.2 Tongue-retaining devices
      • 6.3.2.2.3 Rapid maxillary expansion
      • 6.3.2.2.4 Mouth guards
    • 6.3.2.3 Adaptive servo-ventilation (ASV)
    • 6.3.2.4 Airway clearance system
    • 6.3.2.5 Oxygen devices
    • 6.3.2.6 Other therapeutic devices

Chapter 7 Market Estimates and Forecast, By End Use, 2021 - 2034 ($ Mn)

• 7.1 Key trends
• 7.2 Home care settings and individuals
• 7.3 Sleep laboratories and hospitals

Chapter 8 Market Estimates and Forecast, By Region, 2021 - 2034 ($ Mn)

• 8.1 Key trends
• 8.2 North America
  • 8.2.1 U.S.
  • 8.2.2 Canada
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 UK
  • 8.3.3 France
  • 8.3.4 Spain
  • 8.3.5 Italy
  • 8.3.6 Netherlands
• 8.4 Asia Pacific
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 India
  • 8.4.4 Australia
  • 8.4.5 South Korea
• 8.5 Latin America
  • 8.5.1 Brazil
  • 8.5.2 Mexico
  • 8.5.3 Argentina
• 8.6 Middle East and Africa
  • 8.6.1 South Africa
  • 8.6.2 Saudi Arabia
  • 8.6.3 UAE

Chapter 9 Company Profiles

• 9.1 Apple
• 9.2 Asahi Kasei Corporation
• 9.3 BMC Medical
• 9.4 Cadwell Laboratories
• 9.5 Drive DeVilbiss International
• 9.6 Fisher & Paykel Healthcare
• 9.7 Fitbit
• 9.8 Koninklijke Philips N.V.
• 9.9 LivaNova
• 9.10 Natus Medical
• 9.11 Nihon Kohden
• 9.12 Oura Health
• 9.13 ResMed
• 9.14 Sleep Shepherd
• 9.15 Sleepace
• 9.16 Teleflex
• 9.17 WEINMANN Emergency Medical Technology GmbH + Co. KG
• 9.18 Withings
• 9.19 Xiaomi